lurasidone HCI

FDA Nodded Sunovion’s Latuda for Bipolar Depression in Pediatric Patients

On March 8, 2018, the U.S. Food and Drug Administration approved the expanded use of the anti-psychotic drug Latuda (also referred to as lurasidone HCI) for a new indication – to […]